Salkind Gene 4
4 · Mobiquity Technologies, Inc. · Filed Jan 2, 2025
Insider Transaction Report
Form 4
Salkind Gene
Director10% Owner
Transactions
- Exercise of In-Money
Convertible notes
2024-12-30−210,000→ 411,544 totalExercise: $0.50From: 2024-07-25Exp: 2024-12-31→ Common Stock (420,000 underlying) - Exercise of In-Money
Common Stock
2024-12-30$0.50/sh+420,000$210,000→ 8,643,695 total
Footnotes (3)
- [F1]Not applicable.
- [F2]The securities listed in Table I and Table II are securities owned directly by Dr. Salkind and his wife and by a family trust.
- [F3]Includes (i) 59,211 shares underlying warrants exercisable at $60 per share, (ii) 2,333 shares underlying options exercisable at $68.48 per share, (iii) 100,000 shares underlying options exercisable at $.20 per share and (v) options to purchase 250,000 shares exercisable at $2.45 per share.